{"hands_on_practices": [{"introduction": "The adaptive immune system's ability to recognize a near-infinite array of foreign antigens relies on the immense diversity of the T cell receptor (TCR) repertoire. This astounding diversity is not born from an equally large number of genes, but rather from a clever process of somatic recombination. This exercise will guide you through a first-principles calculation to estimate the scale of this diversity, providing a tangible sense of how a finite set of genetic building blocks can generate a vast, anticipatory defense system ([@problem_id:2773138]).", "problem": "A T cell receptor (TCR) β chain complementarity-determining region 3 (CDR3) sequence is generated by somatic recombination that selects one variable segment, one diversity segment, and one joining segment, followed by exonucleolytic deletions at the coding ends and the addition of random nucleotides by terminal deoxynucleotidyl transferase (TdT). Assume the following idealized model for human TCRβ recombination, focusing on the nucleotide-level sequence of the CDR3 region and ignoring palindromic nucleotides, reading frame constraints, stop codons, selection, and any biases:\n- Segment choice: there are $N_V = 48$ variable segments, $N_D = 2$ diversity segments, and $N_J = 13$ joining segments.\n- Deletion patterns: at each of the four coding ends that form the two junctions (the $3^{\\prime}$ end of $V$, the $5^{\\prime}$ and $3^{\\prime}$ ends of $D$, and the $5^{\\prime}$ end of $J$), exonuclease deletion removes $d \\in \\{0,1,2\\}$ nucleotides, independently across ends.\n- Insertion patterns: at each of the two junctions ($V$–$D$ and $D$–$J$), TdT inserts exactly $N = 4$ nucleotides, each nucleotide independently and uniformly chosen from the four deoxyribonucleotides.\n\nUsing only the above facts and assuming statistical independence among all steps, derive from first principles an expression for the total number of unique nucleotide-level TCRβ CDR3 sequences producible by this process, and then evaluate it for the given parameter values to estimate the order of magnitude. Give your final answer as a single power of ten, $10^{k}$, corresponding to the nearest order of magnitude (i.e., choose the integer $k$ that minimizes $|\\log_{10}(X) - k|$ for your computed count $X$). No units are required.", "solution": "We begin by conducting a formal validation of the problem statement.\n\n**Step 1: Extract Givens**\nThe problem provides the following parameters for a simplified model of human T cell receptor (TCR) β chain recombination:\n- Number of variable (V) segments: $N_V = 48$.\n- Number of diversity (D) segments: $N_D = 2$.\n- Number of joining (J) segments: $N_J = 13$.\n- Exonucleolytic deletion: $d \\in \\{0, 1, 2\\}$ nucleotides are removed independently from each of four coding ends ($V_{3'}$, $D_{5'}$, $D_{3'}$, $J_{5'}$).\n- Nucleotide insertion: exactly $N = 4$ nucleotides are inserted independently at each of the two junctions ($V–D$ and $D–J$).\n- Nucleotide composition: each inserted nucleotide is chosen uniformly and independently from the four possibilities.\n- Core assumptions: All recombination events are statistically independent. Biological constraints such as reading frames, stop codons, protein selection, and any statistical biases in segment usage or enzymatic activity are to be ignored.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is valid. It is scientifically grounded in the accepted molecular mechanism of V(D)J recombination, a fundamental process in adaptive immunity. The parameters provided are realistic for the human TCRβ locus. The problem is well-posed; it supplies all necessary information and assumptions required to derive a unique quantitative answer. The language is objective and precise, defining a tractable combinatorial problem. The simplifications are explicitly stated and are standard for creating a first-order mathematical model of a complex biological system. The problem statement is self-contained, consistent, and does not violate any criteria for invalidity.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid. We shall proceed to derive the solution from first principles.\n\nThe total number of unique nucleotide sequences for the CDR3 region, denoted by $X$, is determined by the product of the number of possibilities at each independent stage of its generation. This is a direct application of the rule of product for counting. The distinct sources of diversity are: (1) the combinatorial selection of gene segments, (2) the variability introduced by exonucleolytic deletions, and (3) the variability from random nucleotide insertions.\n\n$$X = D_{\\text{segmental}} \\times D_{\\text{deletional}} \\times D_{\\text{insertional}}$$\n\n1.  **Segmental Diversity ($D_{\\text{segmental}}$)**\n    This component of diversity arises from choosing one $V$ segment from the available $N_V$ segments, one $D$ segment from the $N_D$ segments, and one $J$ segment from the $N_J$ segments. Since these choices are independent, the total number of segmental combinations is:\n    $$D_{\\text{segmental}} = N_V \\times N_D \\times N_J$$\n\n2.  **Deletional Diversity ($D_{\\text{deletional}}$)**\n    Deletions occur at four independent coding ends: the $3^{\\prime}$ end of the $V$ segment, the $5^{\\prime}$ and $3^{\\prime}$ ends of the $D$ segment, and the $5^{\\prime}$ end of the $J$ segment. At each of these four sites, the number of nucleotides removed can be $0$, $1$, or $2$. This gives $3$ possible outcomes for each site. Given their independence, the total number of unique deletion patterns is:\n    $$D_{\\text{deletional}} = 3 \\times 3 \\times 3 \\times 3 = 3^4$$\n\n3.  **Insertional Diversity ($D_{\\text{insertional}}$)**\n    Nontemplated nucleotides are added by Terminal deoxynucleotidyl Transferase (TdT) at the two junctions: the $V–D$ junction and the $D–J$ junction. At each junction, exactly $N = 4$ nucleotides are inserted. Each of these four positions can be occupied by any of the four deoxyribonucleotides (A, C, G, T). The number of possible insertion sequences for a single junction is therefore $4^N = 4^4$. As the insertions at the two junctions are independent events, the total insertional diversity is the product of the possibilities at each junction:\n    $$D_{\\text{insertional}} = (4^4) \\times (4^4) = 4^8$$\n\n**Total Sequence Diversity and Evaluation**\nBy combining the contributions from all three sources, we obtain the expression for the total number of unique nucleotide-level CDR3 sequences:\n$$X = (N_V \\times N_D \\times N_J) \\times 3^4 \\times 4^8$$\nWe substitute the given values into this expression:\n$$X = (48 \\times 2 \\times 13) \\times 3^4 \\times 4^8$$\nThe problem requires an estimate of the order of magnitude, given as $10^k$, where $k$ is the integer that minimizes $|\\log_{10}(X) - k|$. This is equivalent to finding the integer closest to the value of $\\log_{10}(X)$. We proceed to calculate this value.\n$$\\log_{10}(X) = \\log_{10}(48 \\times 2 \\times 13 \\times 3^4 \\times 4^8)$$\nUsing the logarithmic identity $\\log(abc) = \\log(a) + \\log(b) + \\log(c)$, we can decompose the expression. For maximal precision, we first decompose the arguments into their prime factors:\n$$48 = 16 \\times 3 = 2^4 \\times 3$$\n$$4^8 = (2^2)^8 = 2^{16}$$\nTherefore, the expression for $X$ becomes:\n$$X = (2^4 \\times 3) \\times 2 \\times 13 \\times 3^4 \\times 2^{16}$$\nCollecting terms with the same base:\n$$X = 2^{(4+1+16)} \\times 3^{(1+4)} \\times 13 = 2^{21} \\times 3^5 \\times 13$$\nNow, we take the base-10 logarithm:\n$$\\log_{10}(X) = \\log_{10}(2^{21} \\times 3^5 \\times 13)$$\n$$\\log_{10}(X) = 21\\log_{10}(2) + 5\\log_{10}(3) + \\log_{10}(13)$$\nUsing the standard approximations $\\log_{10}(2) \\approx 0.30103$ and $\\log_{10}(3) \\approx 0.47712$, and the more precise value $\\log_{10}(13) \\approx 1.11394$:\n$$\\log_{10}(X) \\approx 21(0.30103) + 5(0.47712) + 1.11394$$\n$$\\log_{10}(X) \\approx 6.32163 + 2.38560 + 1.11394$$\n$$\\log_{10}(X) \\approx 9.82117$$\nThe integer $k$ closest to $9.82117$ is $10$, since $|9.82117 - 10| = 0.17883$, which is less than $|9.82117 - 9| = 0.82117$.\nThus, the nearest order of magnitude for the total number of unique sequences is $10^{10}$.", "answer": "$$ \\boxed{10^{10}} $$", "id": "2773138"}, {"introduction": "Once a T cell expresses its unique receptor, its activation depends on recognizing a specific peptide fragment presented by a Human Leukocyte Antigen (HLA) molecule. However, the peptide loading process is not random; it is a highly curated competition edited by molecules like HLA-DM. This practice moves beyond simple affinity to explore the kinetic principles that govern which peptides are ultimately displayed on the cell surface, revealing how the immune system selects for stable complexes to ensure a robust and appropriate T cell response ([@problem_id:2773179]).", "problem": "A professional antigen-presenting cell loads peptides onto the Human Leukocyte Antigen-DR (HLA-DR) class II molecule in endosomes where Human Leukocyte Antigen-DM (HLA-DM) acts as a peptide editor. Consider a simplified kinetic model grounded in the law of mass action: peptide loading is governed by association and dissociation reactions characterized by an association rate constant $k_{\\text{on}}$ and a dissociation rate constant $k_{\\text{off}}$, with the equilibrium dissociation constant $K_d = k_{\\text{off}}/k_{\\text{on}}$. Assume that, within the editing compartment, all peptides are present at equal concentration, have equal $k_{\\text{on}}$, and compete for a limiting pool of HLA-DR. Also assume that the set of HLA-DR–peptide complexes that reach the plasma membrane reflects the relative endosomal occupancy at steady state, such that for peptides with equal $k_{\\text{on}}[\\text{peptide}]$, the relative enrichment is dominated by the magnitude of $k_{\\text{off}}$ operating in that compartment. HLA-DM catalyzes peptide exchange by increasing the effective dissociation rate in a peptide-dependent manner; in its absence, the intrinsic $k_{\\text{off}}$ values apply.\n\nYou measure dissociation rates at endosomal pH for $3$ test peptides, $\\mathrm{P}_1$, $\\mathrm{P}_2$, and $\\mathrm{P}_3$, bound to the same HLA-DR allele. The measured values are:\n\n- In the absence of HLA-DM (intrinsic): $k_{\\text{off}}(\\mathrm{P}_1) = 5.0\\times 10^{-6}\\ \\mathrm{s}^{-1}$, $k_{\\text{off}}(\\mathrm{P}_2) = 8.0\\times 10^{-6}\\ \\mathrm{s}^{-1}$, $k_{\\text{off}}(\\mathrm{P}_3) = 1.2\\times 10^{-5}\\ \\mathrm{s}^{-1}$.\n- In the presence of HLA-DM at a fixed, saturating concentration (DM-catalyzed): $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_1) = 5.0\\times 10^{-3}\\ \\mathrm{s}^{-1}$, $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_2) = 1.0\\times 10^{-5}\\ \\mathrm{s}^{-1}$, $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_3) = 1.5\\times 10^{-5}\\ \\mathrm{s}^{-1}$.\n\nUnder these assumptions, which choice best predicts which peptide will be relatively enriched among HLA-DR–peptide complexes at the cell surface in the absence versus the presence of HLA-DM?\n\nA. Absence of HLA-DM: $\\mathrm{P}_1$; Presence of HLA-DM: $\\mathrm{P}_1$.\n\nB. Absence of HLA-DM: $\\mathrm{P}_1$; Presence of HLA-DM: $\\mathrm{P}_2$.\n\nC. Absence of HLA-DM: $\\mathrm{P}_2$; Presence of HLA-DM: $\\mathrm{P}_3$.\n\nD. Absence of HLA-DM: $\\mathrm{P}_3$; Presence of HLA-DM: $\\mathrm{P}_2$.", "solution": "The problem statement will first be subjected to a rigorous validation.\n\n### Problem Validation\n\n**Step 1: Extracted Givens**\n\nThe problem provides a simplified kinetic model for peptide loading onto the Human Leukocyte Antigen-DR (HLA-DR) molecule, modulated by the peptide editor Human Leukocyte Antigen-DM (HLA-DM).\n\n-   **System**: Peptide competition for a limiting pool of HLA-DR in an endosomal compartment.\n-   **Kinetics**: The binding and dissociation are described by an association rate constant $k_{\\text{on}}$ and a dissociation rate constant $k_{\\text{off}}$. The equilibrium dissociation constant is $K_d = k_{\\text{off}}/k_{\\text{on}}$.\n-   **Assumptions**:\n    1.  All peptides ($P_i$) are present at equal concentration, $[P_i] = \\text{constant}$.\n    2.  All peptides have an equal association rate constant, $k_{\\text{on}, i} = \\text{constant}$.\n    3.  The pool of HLA-DR is limiting.\n    4.  HLA-DR–peptide complex presentation at the cell surface reflects the relative endosomal occupancy at steady state.\n    5.  For peptides with equal $k_{\\text{on}}[\\text{peptide}]$, relative enrichment is dominated by the magnitude of $k_{\\text{off}}$.\n-   **Peptides**: $3$ test peptides are denoted $\\mathrm{P}_1$, $\\mathrm{P}_2$, and $\\mathrm{P}_3$.\n-   **Data (Measured Dissociation Rates)**:\n    -   In the absence of HLA-DM (intrinsic rate):\n        -   $k_{\\text{off}}(\\mathrm{P}_1) = 5.0\\times 10^{-6}\\ \\mathrm{s}^{-1}$\n        -   $k_{\\text{off}}(\\mathrm{P}_2) = 8.0\\times 10^{-6}\\ \\mathrm{s}^{-1}$\n        -   $k_{\\text{off}}(\\mathrm{P}_3) = 1.2\\times 10^{-5}\\ \\mathrm{s}^{-1}$\n    -   In the presence of HLA-DM (catalyzed rate):\n        -   $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_1) = 5.0\\times 10^{-3}\\ \\mathrm{s}^{-1}$\n        -   $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_2) = 1.0\\times 10^{-5}\\ \\mathrm{s}^{-1}$\n        -   $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_3) = 1.5\\times 10^{-5}\\ \\mathrm{s}^{-1}$\n\n**Step 2: Validation Using Extracted Givens**\n\nThe problem is assessed for validity.\n-   **Scientifically Grounded**: The problem describes a simplified but fundamentally correct model of peptide-MHC class II loading and editing by HLA-DM. The concepts of association/dissociation rates, steady-state occupancy, and the catalytic role of HLA-DM are central tenets of cellular immunology. The provided kinetic values are within a plausible range for such biological interactions. This is a valid problem in general biology.\n-   **Well-Posed**: The problem provides a clear set of assumptions and quantitative data. The question asks for a prediction based on these assumptions. A unique solution is derivable from the provided information. The phrase \"relative enrichment is dominated by the magnitude of $k_{\\text{off}}$\" provides a direct instruction for solving the problem.\n-   **Objective**: The problem is stated in precise, technical language, free from subjective or ambiguous terms.\n-   **Conclusion**: The problem is scientifically sound, self-contained, and well-posed. There are no contradictions, missing information, or logical flaws.\n\n**Verdict**: The problem is **valid**.\n\n### Solution Derivation\n\nThe problem requires us to determine which peptide will be relatively enriched on the cell surface, which, according to the stated assumptions, is determined by the relative endosomal occupancy of HLA-DR–peptide complexes at steady state.\n\nThe formation of an HLA-DR–peptide complex, which we denote as $[\\text{DR-P}]$, follows the law of mass action for a reversible reaction:\n$$ \\text{DR}_{\\text{free}} + \\text{P} \\underset{k_{\\text{off}}}{\\stackrel{k_{\\text{on}}}{\\rightleftharpoons}} \\text{DR-P} $$\nAt steady state, the rate of complex formation equals the rate of complex dissociation:\n$$ k_{\\text{on}} [\\text{DR}_{\\text{free}}] [\\text{P}] = k_{\\text{off}} [\\text{DR-P}] $$\nThe concentration of a given HLA-DR-peptide complex, $[\\text{DR-P}_i]$, can be expressed as:\n$$ [\\text{DR-P}_i] = \\frac{k_{\\text{on}, i}}{k_{\\text{off}, i}} [\\text{DR}_{\\text{free}}] [\\text{P}_i] $$\nThe problem states that for all peptides, the concentration $[\\text{P}_i]$ is equal and the association rate constant $k_{\\text{on}, i}$ is equal. Therefore, the term $k_{\\text{on}, i} [\\text{P}_i]$ is a constant for all peptides under consideration. The concentration of free HLA-DR, $[\\text{DR}_{\\text{free}}]$, is also common to all competing reactions.\nThus, the steady-state occupancy for a given peptide $i$ is inversely proportional to its dissociation rate constant:\n$$ [\\text{DR-P}_i] \\propto \\frac{1}{k_{\\text{off}, i}} $$\nThe peptide that is \"relatively enriched\" will be the one with the highest steady-state concentration, which corresponds to the one with the **lowest** dissociation rate constant ($k_{\\text{off}}$). A lower $k_{\\text{off}}$ signifies a more stable complex with a longer half-life ($t_{1/2} = \\ln(2)/k_{\\text{off}}$).\n\nWe must apply this principle to the two specified conditions.\n\n**Case 1: Absence of HLA-DM**\nWe compare the intrinsic dissociation rates, $k_{\\text{off}}$.\n-   $k_{\\text{off}}(\\mathrm{P}_1) = 5.0 \\times 10^{-6}\\ \\mathrm{s}^{-1}$\n-   $k_{\\text{off}}(\\mathrm{P}_2) = 8.0 \\times 10^{-6}\\ \\mathrm{s}^{-1}$\n-   $k_{\\text{off}}(\\mathrm{P}_3) = 1.2 \\times 10^{-5}\\ \\mathrm{s}^{-1} = 12.0 \\times 10^{-6}\\ \\mathrm{s}^{-1}$\n\nComparing these values:\n$$ 5.0 \\times 10^{-6}\\ \\mathrm{s}^{-1} < 8.0 \\times 10^{-6}\\ \\mathrm{s}^{-1} < 12.0 \\times 10^{-6}\\ \\mathrm{s}^{-1} $$\n$$ k_{\\text{off}}(\\mathrm{P}_1) < k_{\\text{off}}(\\mathrm{P}_2) < k_{\\text{off}}(\\mathrm{P}_3) $$\nThe lowest dissociation rate belongs to peptide $\\mathrm{P}_1$. Consequently, in the absence of HLA-DM, $\\mathrm{P}_1$ forms the most stable complexes and will be relatively enriched.\n\n**Case 2: Presence of HLA-DM**\nWe compare the HLA-DM-catalyzed dissociation rates, $k_{\\text{off}}^{\\text{DM}}$.\n-   $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_1) = 5.0 \\times 10^{-3}\\ \\mathrm{s}^{-1} = 500.0 \\times 10^{-5}\\ \\mathrm{s}^{-1}$\n-   $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_2) = 1.0 \\times 10^{-5}\\ \\mathrm{s}^{-1}$\n-   $k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_3) = 1.5 \\times 10^{-5}\\ \\mathrm{s}^{-1}$\n\nComparing these values:\n$$ 1.0 \\times 10^{-5}\\ \\mathrm{s}^{-1} < 1.5 \\times 10^{-5}\\ \\mathrm{s}^{-1} < 5.0 \\times 10^{-3}\\ \\mathrm{s}^{-1} $$\n$$ k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_2) < k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_3) < k_{\\text{off}}^{\\text{DM}}(\\mathrm{P}_1) $$\nThe lowest dissociation rate in the presence of the catalytic editor HLA-DM belongs to peptide $\\mathrm{P}_2$. This signifies that the $\\mathrm{DR}$-$\\mathrm{P}_2$ complex is the most resistant to HLA-DM-mediated dissociation. In contrast, the intrinsically most stable complex, $\\mathrm{DR}$-$\\mathrm{P}_1$, is extremely susceptible to HLA-DM catalysis, and its $k_{\\text{off}}$ increases by a factor of $1000$. Therefore, in the presence of HLA-DM, peptide $\\mathrm{P}_2$ will be relatively enriched.\n\n**Conclusion**:\n-   In the absence of HLA-DM, $\\mathrm{P}_1$ is enriched.\n-   In the presence of HLA-DM, $\\mathrm{P}_2$ is enriched.\n\n### Option Analysis\n\n-   **A. Absence of HLA-DM: $\\mathrm{P}_1$; Presence of HLA-DM: $\\mathrm{P}_1$.**\n    The first part is correct. The second part is incorrect, as $\\mathrm{P}_1$ is the most rapidly dissociated peptide in the presence of HLA-DM.\n    **Verdict: Incorrect.**\n\n-   **B. Absence of HLA-DM: $\\mathrm{P}_1$; Presence of HLA-DM: $\\mathrm{P}_2$.**\n    This matches our derived conclusions precisely. $\\mathrm{P}_1$ has the lowest intrinsic $k_{\\text{off}}$. $\\mathrm{P}_2$ has the lowest DM-catalyzed $k_{\\text{off}}^{\\text{DM}}$.\n    **Verdict: Correct.**\n\n-   **C. Absence of HLA-DM: $\\mathrm{P}_2$; Presence of HLA-DM: $\\mathrm{P}_3$.**\n    The first part is incorrect; $\\mathrm{P}_1$ is enriched in the absence of HLA-DM. The second part is also incorrect; $\\mathrm{P}_2$ is enriched in the presence of HLA-DM.\n    **Verdict: Incorrect.**\n\n-   **D. Absence of HLA-DM: $\\mathrm{P}_3$; Presence of HLA-DM: $\\mathrm{P}_2$.**\n    The first part is incorrect; $\\mathrm{P}_3$ has the highest intrinsic $k_{\\text{off}}$ and would be the least enriched. The second part is correct. Since the first part is false, the entire option is incorrect.\n    **Verdict: Incorrect.**", "answer": "$$\\boxed{B}$$", "id": "2773179"}, {"introduction": "A successful immune response requires that a few rare, antigen-specific T cells undergo massive proliferation to form an effective army of effector cells. This practice applies the principles of population dynamics to model this explosive clonal expansion during an acute infection. By constructing a simple birth-death model, you will quantify the magnitude of this expansion and compare theoretical predictions with empirical data, bridging the gap between single-cell activation and the population-level response that clears pathogens ([@problem_id:2773156]).", "problem": "In an acute viral infection, a single naive antigen-specific cytotoxic T lymphocyte clone (cluster of differentiation 8 positive cytotoxic T lymphocyte, CD8 CTL) recognizable by its unique T cell receptor (TCR) expands upon encountering antigen on professional antigen-presenting cells. Consider the following biologically grounded scenario for a single epitope-specific clone in a mouse. The total circulating and lymphoid pool of CD8 T cells is $N_{\\mathrm{tot}} = 5 \\times 10^{7}$ cells. The naive precursor frequency for this epitope is $f_{0} = 2.0 \\times 10^{-6}$, so the initial clone size is $N_{0} = f_{0} N_{\\mathrm{tot}}$. During the expansion phase of length $T = 6$ days, each activated cell divides with a constant division time $\\tau_{\\mathrm{div}} = \\tfrac{1}{3}$ day and dies with a per-capita death rate $\\delta = 0.20 \\ \\mathrm{day}^{-1}$. The target peak effector pool for this clone is $E_{\\mathrm{target}} = 2.0 \\times 10^{6}$ cells. Empirical studies of dominant epitope-specific clones in acute infections report an observed fold expansion of $F_{\\mathrm{obs}} = 5.0 \\times 10^{4}$.\n\nUse a continuous-time birth–death model grounded in population dynamics. Assume that the per-capita division rate is related to the division time by $r = \\ln(2)/\\tau_{\\mathrm{div}}$, and that the net growth rate is $r - \\delta$, yielding exponential dynamics $N(t) = N_{0} \\exp\\!\\big((r - \\delta) t\\big)$ during the expansion phase.\n\nTasks:\n- Compute the fold expansion required to reach the target effector pool, $F_{\\mathrm{needed}} = E_{\\mathrm{target}}/N_{0}$.\n- Compute the model-predicted fold expansion over the expansion phase, $F_{\\mathrm{model}} = \\exp\\!\\big((r - \\delta) T\\big)$.\n- Define the comparison metric $Q = F_{\\mathrm{model}}/F_{\\mathrm{obs}}$.\n\nWhat is the value of $Q$? Round your final answer to three significant figures. Provide a dimensionless result (no units).", "solution": "The problem requires the computation of a comparison metric, $Q$, which relates a model-predicted T cell clonal expansion to an empirically observed value. The model is a continuous-time birth-death process. We will proceed by first calculating the necessary intermediate quantities as defined in the problem statement.\n\nThe provided parameters are:\n- Total initial CD$8$ T cell pool: $N_{\\mathrm{tot}} = 5 \\times 10^{7}$\n- Naive precursor frequency: $f_{0} = 2.0 \\times 10^{-6}$\n- Duration of expansion phase: $T = 6$ days\n- Cell division time: $\\tau_{\\mathrm{div}} = \\frac{1}{3}$ day\n- Per-capita death rate: $\\delta = 0.20 \\ \\mathrm{day}^{-1}$\n- Target peak effector pool size: $E_{\\mathrm{target}} = 2.0 \\times 10^{6}$\n- Observed fold expansion: $F_{\\mathrm{obs}} = 5.0 \\times 10^{4}$\n\nFirst, we determine the initial size of the antigen-specific T cell clone, $N_{0}$.\n$$N_{0} = f_{0} N_{\\mathrm{tot}}$$\nSubstituting the given values:\n$$N_{0} = (2.0 \\times 10^{-6}) \\times (5 \\times 10^{7}) = 10 \\times 10^{1} = 100 \\ \\text{cells}$$\n\nThe problem defines a task to compute the fold expansion required to reach the target effector pool, $F_{\\mathrm{needed}}$.\n$$F_{\\mathrm{needed}} = \\frac{E_{\\mathrm{target}}}{N_{0}}$$\nUsing our calculated $N_{0}$ and the given $E_{\\mathrm{target}}$:\n$$F_{\\mathrm{needed}} = \\frac{2.0 \\times 10^{6}}{100} = 2.0 \\times 10^{4}$$\n\nNext, we compute the model-predicted fold expansion, $F_{\\mathrm{model}}$. The dynamics are given by $N(t) = N_{0} \\exp((r - \\delta) t)$, so the fold expansion over a period $T$ is $N(T)/N_{0}$, which is:\n$$F_{\\mathrm{model}} = \\exp((r - \\delta) T)$$\nTo evaluate this, we must first find the per-capita division rate, $r$. It is related to the division time, $\\tau_{\\mathrm{div}}$, by the formula for conversion from a discrete division event to a continuous rate:\n$$r = \\frac{\\ln(2)}{\\tau_{\\mathrm{div}}}$$\nWith $\\tau_{\\mathrm{div}} = \\frac{1}{3} \\ \\mathrm{day}$:\n$$r = \\frac{\\ln(2)}{1/3} = 3 \\ln(2) \\ \\mathrm{day}^{-1}$$\n\nNow, we calculate the net growth rate, $k = r - \\delta$.\n$$k = 3 \\ln(2) - 0.20 \\ \\mathrm{day}^{-1}$$\n\nWe can now compute $F_{\\mathrm{model}}$ using the expansion time $T = 6$ days.\n$$F_{\\mathrm{model}} = \\exp(k T) = \\exp\\left((3 \\ln(2) - 0.20) \\times 6\\right)$$\n$$F_{\\mathrm{model}} = \\exp(18 \\ln(2) - 1.2) = \\exp(\\ln(2^{18})) \\exp(-1.2) = 2^{18} \\exp(-1.2)$$\nEvaluating this expression:\n$$F_{\\mathrm{model}} = 262144 \\times \\exp(-1.2) \\approx 262144 \\times 0.301194$$\n$$F_{\\mathrm{model}} \\approx 78945.8$$\n\nFinally, we compute the comparison metric $Q$, defined as the ratio of the model-predicted expansion to the observed expansion.\n$$Q = \\frac{F_{\\mathrm{model}}}{F_{\\mathrm{obs}}}$$\nSubstituting the values for $F_{\\mathrm{model}}$ and $F_{\\mathrm{obs}} = 5.0 \\times 10^{4}$:\n$$Q = \\frac{78945.8}{5.0 \\times 10^{4}} \\approx 1.578916$$\nRounding the result to three significant figures, as required, we obtain $1.58$. This dimensionless value indicates that the simple exponential growth model predicts an expansion that is approximately $1.58$ times larger than what is typically observed for dominant epitopes.", "answer": "$$\\boxed{1.58}$$", "id": "2773156"}]}